C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Buys 43,075 Shares of Global X HealthTech ETF $HEAL

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors lifted its stake in shares of Global X HealthTech ETF (NASDAQ:HEAL) by 28.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 195,122 shares of the company’s stock after acquiring an additional 43,075 shares during the quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors owned about 18.58% of Global X HealthTech ETF worth $5,758,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. WT Wealth Management lifted its holdings in Global X HealthTech ETF by 14.7% in the 1st quarter. WT Wealth Management now owns 101,116 shares of the company’s stock worth $2,409,000 after purchasing an additional 12,945 shares during the last quarter. Farther Finance Advisors LLC raised its position in shares of Global X HealthTech ETF by 4.3% in the third quarter. Farther Finance Advisors LLC now owns 23,037 shares of the company’s stock valued at $680,000 after purchasing an additional 950 shares during the period. Finally, Royal Bank of Canada raised its position in shares of Global X HealthTech ETF by 39.4% in the first quarter. Royal Bank of Canada now owns 2,603 shares of the company’s stock valued at $62,000 after purchasing an additional 736 shares during the period.

Global X HealthTech ETF Price Performance

Global X HealthTech ETF stock opened at $29.51 on Thursday. The firm has a market cap of $30.99 million, a price-to-earnings ratio of 42.80 and a beta of 1.13. Global X HealthTech ETF has a fifty-two week low of $23.00 and a fifty-two week high of $33.30. The firm has a fifty day moving average price of $29.29 and a two-hundred day moving average price of $27.14.

Global X HealthTech ETF Profile

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.